Internal Medicine, Rheumatology · Murfreesboro, TN
NPI
1790758514
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1272 Garrison Dr
Murfreesboro, TN, 37129
Phone (615) 867-8200
Groups this clinician bills Medicare through
Medicare paid, 2024
$938K
67,491 services
Medicare patients, 2024
358
Average age 74
Drug cost, 2024
$3.3M
3,920 prescriptions
Company payments, 2025
$1,085
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asim Razzaq was code J1602 (injection, golimumab, 1 mg, for intravenous use), 20,050 times for 24 patients. In total Asim Razzaq billed 67,491 services in 60 codes, and Medicare paid $938K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 20,050 | 24 | $9.04 | $181K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 8,175 | 15 | $33.86 | $277K |
| J0897 Injection, denosumab, 1 mg | Office | 2,162 | 24 | $19.94 | $43K |
| 99214 Office E&M - Established | Office | 549 | 255 | $82.94 | $46K |
| 36415 Venipuncture Blood Collection | Office | 473 | 251 | $8.64 | $4,085 |
| 80053 Clinical Chemistry | Office | 397 | 224 | $10.31 | $4,092 |
| 85025 Blood Count | Office | 361 | 193 | $7.58 | $2,736 |
| 86140 Clinical Chemistry | Office | 342 | 170 | $5.08 | $1,737 |
| 85652 Clinical Chemistry | Office | 341 | 166 | $2.64 | $902 |
| 96365 Intravenous Infusion, Hydration | Office | 228 | 57 | $42.14 | $9,608 |
| 99204 Office E&M - New | Office | 91 | 91 | $107.23 | $9,758 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 90 | 18 | $5.09 | $458 |
| 82306 Clinical Chemistry | Office | 88 | 85 | $29.01 | $2,553 |
| 96413 Chemotherapy Administration | Office | 85 | 21 | $88.78 | $7,546 |
| 99213 Office E&M - Established | Office | 70 | 59 | $54.67 | $3,827 |
By year: 2022 $1.2M for 79,204 services; 2023 $1.1M for 70,598 services; 2024 $938K for 67,491 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 473 | 251 | $8.64 | $4,085 |
| 80053 Clinical Chemistry | 397 | 224 | $10.31 | $4,092 |
| 85025 Blood Count | 361 | 193 | $7.58 | $2,736 |
| 86140 Clinical Chemistry | 342 | 170 | $5.08 | $1,737 |
| 85652 Clinical Chemistry | 341 | 166 | $2.64 | $902 |
| 82306 Clinical Chemistry | 88 | 85 | $29.01 | $2,553 |
| 81001 Clinical Chemistry | 43 | 41 | $3.11 | $134 |
| 84550 Clinical Chemistry | 38 | 30 | $4.43 | $168 |
| 82550 Clinical Chemistry | 31 | 28 | $6.38 | $198 |
| 82607 Clinical Chemistry | 19 | 16 | $14.78 | $281 |
Medicare prescription drug claims, 2024
In 2024, the drug Asim Razzaq prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 797 prescriptions and refills. In total Asim Razzaq wrote 3,920 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 797 | 1,225 | 160 | $22K |
| Methotrexate Methotrexate Sodium | 618 | 929 | 126 | $13K |
| Prednisone Generic | 255 | 288 | 61 | $1,148 |
| Alendronate Sodium Generic | 211 | 347 | 48 | $1,160 |
| Duloxetine Hcl Generic | 161 | 271 | 39 | $2,441 |
| Folic Acid Generic | 154 | 293 | 40 | $551 |
| Leflunomide Generic | 146 | 214 | 31 | $11K |
| Sulfasalazine Generic | 123 | 203 | 32 | $2,516 |
| Allopurinol Generic | 111 | 222 | 34 | $1,139 |
| Famotidine Generic | 110 | 196 | 37 | $673 |
| Celecoxib Generic | 109 | 147 | 29 | $1,792 |
| Enbrel Mini Etanercept | 109 | 109 | 13 | $834K |
| Rinvoq Upadacitinib | 89 | 89 | 14 | $567K |
| Humira(Cf) Pen Adalimumab | 65 | 69 | 12 | $458K |
| Gabapentin Generic | 59 | 61 | 11 | $563 |
Brand drugs: - claims; generic drugs: 3,273 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asim Razzaq $1,085 ($1,085 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $336.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $336 |
| Amgen Inc. AMGN | 19 | $188 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $124 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $109 |
| Janssen Biotech, Inc. JNJ | 1 | $99 |
| Genzyme Corporation SNY | 4 | $86.24 |
| GlaxoSmithKline, LLC. GSK | 4 | $83.11 |
| UCB, Inc. UCB.BR | 1 | $21.81 |
| Ferring Pharmaceuticals Inc. | 1 | $19.76 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $18.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.